The blind spot in high-dose tigecycline pharmacokinetics in critically ill patients: membrane adsorption during continuous extracorporeal treatment

Crit Care. 2015 Jan 28;19(1):24. doi: 10.1186/s13054-015-0744-9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Critical Illness / therapy*
  • Drug Resistance, Multiple, Bacterial / drug effects*
  • Female
  • Gram-Negative Bacterial Infections / drug therapy*
  • Humans
  • Male
  • Minocycline / analogs & derivatives*
  • Severity of Illness Index*

Substances

  • Anti-Bacterial Agents
  • Minocycline